Johnson & Johnson’s $55bn bet: What it means for healthcare and investors

Pallavi Madhiraju- March 22, 2025 0

Johnson & Johnson is investing $55 billion in U.S. manufacturing, R&D, and technology, reinforcing its leadership in pharmaceuticals. Find out more. Read More

Inside Lilly’s $50bn push to transform American drug production

Pallavi Madhiraju- February 27, 2025 0

Eli Lilly and Company (Lilly) has unveiled an ambitious plan to more than double its U.S. manufacturing investment, committing over $50 billion since 2020. This ... Read More

Orchid Pharma secures USFDA approval, reinforcing global leadership in sterile cephalosporins

Pallavi Madhiraju- February 20, 2025 0

Orchid Pharma Limited has reaffirmed its position as a leading pharmaceutical manufacturer with the successful completion of a surprise inspection by the U.S. Food and ... Read More

Lilly commits $3bn to Wisconsin facility to boost injectable medicine production

Pallavi Madhiraju- December 6, 2024 0

Eli Lilly and Company (Lilly) has unveiled plans for a $3 billion expansion of its newly acquired manufacturing facility in Kenosha County, Wisconsin, signalling a ... Read More

PCI Pharma Services achieves milestone with successful ICMRA inspection at Bedford facility

Pallavi Madhiraju- August 22, 2024 0

PCI Pharma Services, a leading global contract development and manufacturing organization (CDMO), has reached a significant milestone by successfully completing the International Coalition of Medicines ... Read More

Lupin Limited secures major victory: A perfect FDA score for its Gujarat plant

Pallavi Madhiraju- July 13, 2024 0

Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). ... Read More

Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets

Pallavi Madhiraju- July 4, 2024 0

Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More

Novo Nordisk announces $4.1bn investment in new North Carolina manufacturing facility

Pallavi Madhiraju- June 25, 2024 0

Novo Nordisk, a global leader in pharmaceutical manufacturing, has unveiled plans to invest $4.1 billion (approximately 27 billion Danish kroner) to establish a second fill ... Read More

Vetter announces major global expansion with investments in US and Germany

Pallavi Madhiraju- June 6, 2024 0

Vetter, a leading global contract development and manufacturing organization (CDMO), has unveiled significant expansion plans, which include relocating and enlarging its Development Services site in ... Read More

Ingersoll Rand announces $2.3bn acquisition of ILC Dover from New Mountain Capital

Pallavi Madhiraju- March 25, 2024 0

Ingersoll Rand Inc. (NYSE:IR), renowned for its mission-critical flow creation and industrial solutions, has entered a definitive agreement to acquire ILC Dover from New Mountain ... Read More

1210 / 17 Posts